Trials / Unknown
UnknownNCT03963362
The Pharmacokinetics of GLA5PR Tablet According to the Renal Function
Clinical Study to Evaluate Pharmacokinetics of GLA5PR Tablet According to the Renal Function
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- GL Pharm Tech Corporation · Industry
- Sex
- All
- Age
- 19 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
To evauate pharmacokinetics of GLA5PR tablet according to the renal function
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GLA5PR tablet 75 mg | GLARS-NF3 tablet |
| DRUG | GLA5PR tablet 150 mg | GLARS-NF3 tablet |
Timeline
- Start date
- 2019-09-17
- Primary completion
- 2020-12-31
- Completion
- 2021-06-30
- First posted
- 2019-05-24
- Last updated
- 2020-07-23
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03963362. Inclusion in this directory is not an endorsement.